rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TENX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      TENX UPCOMING DEADLINE: Levi & Korsinsky Alerts Tenax Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
      Nov 11MorningstarTENX
      Tenax Therapeutics (TENX) Upgraded to Buy: Here's Why
      Nov 9Yahoo FinanceTENX
      TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit
      Nov 7MorningstarTENX
      TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law
      Nov 7MorningstarTENX
      What Should Tenax Therapeutics, Inc. Investors Know After 89.77% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
      Nov 6MorningstarTENX
      Tenax Therapeutics: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceTENX
      Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

      Completed Statistical Analyses of LEVEL Yielded a Predictive Enrichment Strategy Being Applied in Amended LEVEL-2 Protocol Company Has Been Granted a Type C Meeting with the FDA CHAPEL HILL, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) today reported financial results for the quarter ended September 30, 2026 and provided an update on recent corporate progress. On August 10, 2026, Tenax announced that LEVEL, the

      Nov 5Yahoo FinanceTENX
      SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm.
      Oct 30MorningstarTENX
      TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit
      Oct 28MorningstarTENX
      Tenax Therapeutics (TENX) Stock Fair Value Falls After Cautious Analyst Calls On LEVEL Data
      Oct 25Yahoo FinanceTENX
      Adar1 Capital Management, a 10% owner, buys $1.46m of Tenax Therapeutics
      Oct 22Investing.comTENX
      12 Health Care Stocks Moving In Wednesday's After-Market Session
      Oct 21BenzingaTENXTPST
      Tenax Therapeutics director Declan Doogan buys $101,760 in shares
      Sep 17Investing.comTENX
      Piper Sandler Remains a Buy on Tenax Therapeutics (TENX)

      Detailed price information for Tenax Therapeutics (TENX-Q) from The Globe and Mail including charting and trades.

      Sep 16The Globe and MailTENX
      Tenax Therapeutics CFO buys $10,981 in common stock
      Sep 16Investing.comTENX
      Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares
      Sep 15Investing.comTENX
      Wall Street Analysts Are Bullish on Top Healthcare Picks

      Detailed price information for Kura Oncology (KURA-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailTENX
      Cantor Fitzgerald reiterates Tenax Therapeutics stock rating at overweight
      Sep 10Investing.comTENX
      Tenax Therapeutics, Inc. (TENX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
      Sep 9Seeking AlphaTENX
      Adar1 Capital Management, 10% owner, buys $1.6m in Tenax Therapeutics
      Sep 9Investing.comTENX
      Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?

      Tenax Therapeutics, Inc. (NASDAQ:TENX) has a possible route forward for TNX-103, but the Phase 3 LEVEL trial did not establish efficacy in the overall population. The study evaluated oral levosimendan in 241 patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or PH-HFpEF. At Week 12, the adjusted improvement in six-minute walk […]

      Sep 4Yahoo FinanceTENX
      Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

      CHAPEL HILL, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that Chris Giordano, President & Chief Executive Officer, will present at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 a.m. ET. The live and archived webcast of the presentation will be accessible from the Company’s investor relations webpage. About Tenax TherapeuticsTenax Therapeutics, Inc. is a P

      Sep 1Yahoo FinanceTENX
      Why is Tenax Therapeutics stock volatile today?
      Aug 31Investing.comTENX
      Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy
      Aug 31Yahoo FinanceTENX
      Tenax finds benefit in sicker patient subgroup after Phase 3 trial miss (TENX:NASDAQ)

      Tenax (TENX) Phase 3 TNX-103 missed endpoints, but subgroup data show improved walking distance in PH-HFpEF.

      Aug 30Seeking AlphaTENX
      Tenax presents additional Phase 3 trial data for TNX-103
      Aug 29Investing.comTENX
      Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

      In patients with a baseline 6MWD below the trial median of 333 meters, treatment with TNX-103 resulted in a 26.3-meter improvement compared to placebo (p = 0.0112) In the same patient population, TNX-103 produced a 47% reduction in NT-proBNP (p < 0.0001) and a 4.9 mmHg reduction in RVSP (p = 0.009) compared to placebo With full statistics analysis now complete, Company confirms TNX-103’s biological effects include marked reductions in pulmonary artery pressure and NT-proBNP, a biomarker reflecti

      Aug 29Yahoo FinanceTENX
      Tenax rises on over $1.8M insider buying (TENX:NASDAQ)
      Aug 25Seeking AlphaTENX
      Adar1 Capital Management buys $1.8m of Tenax Therapeutics (TENX) shares
      Aug 24Investing.comTENX

      This is the newest page. Registered accounts read further back.